Urgent

Residual neuromuscular blockade / recurarisation

Incomplete reversal · Perioperative & Anaesthesia
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Persistent or recurring neuromuscular weakness after anaesthesia from incompletely reversed non-depolarising block (TOF ratio <0.9), risking airway obstruction, hypoventilation and aspiration in recovery. Recurarisation describes return of block after apparent reversal.

Red flags

  • Upper airway obstruction or tracheal tug in recovery
  • Hypoventilation with rising CO2 and falling SpO2
  • Inability to sustain head lift or maintain airway
  • Weakness recurring after apparent reversal (recurarisation)
  • Aspiration or regurgitation during weakness
  • Agitation/distress from paralysis with inadequate ventilation

Assessment

Differential diagnosis

  • Inadequate dose/timing of reversal relative to depth of block
  • Neostigmine ceiling effect given at deep block (reappearance of block)
  • Renal/hepatic impairment prolonging relaxant or reversal clearance
  • Potentiating factors (hypothermia, acidosis, hypokalaemia, hypermagnesaemia, aminoglycosides)
  • Neuromuscular disease (myasthenia gravis, Eaton-Lambert)
  • Sugammadex re-dosing errors or displacement by other drugs

Investigations

  • Quantitative train-of-four monitoring (aim TOF ratio >0.9)
  • Clinical tests: sustained 5-second head lift, hand grip, tongue protrusion, adequate tidal volume
  • ABG if hypoventilating (rising CO2)
  • Electrolytes, magnesium, renal function, temperature
  • Review relaxant and reversal doses and timing

Management

  • Suspect residual block in any post-extubation weakness, jerky breathing, tracheal tug or desaturation
  • Support the airway, give oxygen and assist ventilation as needed
  • Confirm with quantitative TOF monitoring rather than clinical signs alone
  • If rocuronium/vecuronium block, give sugammadex at the appropriate dose for depth
  • If other relaxants and shallow block with intact TOF response, give neostigmine with an antimuscarinic
  • Correct potentiating factors: warm the patient, correct acidosis, electrolytes
  • Keep the patient sitting up and monitored until full recovery confirmed
  • Avoid sedatives/opioids that worsen hypoventilation until recovered
  • Re-intubate if airway/ventilation inadequate
  • Document and investigate predisposing causes

Drugs & doses

Sugammadex 2 mg/kg IV (TOF reappearing), 4 mg/kg IV (deep block, 1-2 post-tetanic counts), 16 mg/kg for immediate reversal
Neostigmine 0.04-0.05 mg/kg IV (max ~5 mg) with glycopyrrolate 10-15 microgram/kg or atropine
Avoid neostigmine at very deep block (can worsen/prolong)
Calcium or correction of hypermagnesaemia if contributory
Oxygen and airway support as needed

Disposition

Keep in a monitored recovery area until quantitative reversal is confirmed; patients with recurrent weakness, high CO2 or aspiration need critical care and consultant review.

Complications & pitfalls

  • Hypoxaemia and hypercapnia
  • Aspiration pneumonitis
  • Airway obstruction/arrest
  • Awareness if sedation lifts before paralysis
  • Postoperative respiratory failure/reintubation

Exam pearls

  • Clinical signs are unreliable; only quantitative TOF ratio >0.9 confirms adequate reversal
  • Neostigmine has a ceiling and can paradoxically worsen very deep block; sugammadex is depth-appropriate for aminosteroid relaxants
  • Hypothermia, acidosis and hypomagnesaemia all prolong block
  • Giving sugammadex too early relative to re-anaesthesia, or a second aminosteroid soon after, risks errors
  • Sit the patient up and keep monitoring; recurarisation can appear in recovery

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.